Figure 4.
Change from baseline in a.m. PEF in subjects from the SLIC trial who were treated with salmeterol and constant triamcinolone dose throughout entire trial period, in B16Arg/Arg and B16Gly/Gly subjects; p values are for comparisons between genotype groups at the end of the randomized treatment period (Week 18). Each line represents linear segmental depictions of mean data.